Risk factors for cardiovascular disease and mortality events in adults with type 2 diabetes-a 10-year follow-up: Tehran Lipid and Glucose Study

被引:28
|
作者
Afsharian, Sheila [1 ]
Akbarpour, Samaneh [1 ]
Abdi, Hengameh [2 ]
Sheikholeslami, Farhad [1 ]
Moeini, Ali Siamak [1 ]
Khalili, Davood [1 ]
Momenan, Amir Abbas [1 ]
Azizi, Fereidoun [2 ]
Hadaegh, Farzad [1 ]
机构
[1] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran
关键词
type; 2; diabetes; cardiovascular disease; mortality; risk factors; health policy; CORONARY-HEART-DISEASE; BODY-MASS INDEX; FASTING GLUCOSE; POPULATION; MELLITUS; ASSOCIATION; MEN; PREVALENCE; OVERWEIGHT; PREVENTION;
D O I
10.1002/dmrr.2776
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background To identify risk factors for cardiovascular disease (CVD) and mortality events in patients with type 2 diabetes and to calculate their population attributable fraction among a representative Iranian population. Methods A total of 1198 patients with type 2 diabetes (504 men and 694 women), aged >= 30 years, without prevalent CVD, with a median follow-up of 10 years were included in current study. To examine the association between risk factors and their outcomes, multivariate sex-adjusted Cox proportional hazard regression models were used. Results During the study, 281 and 172 participants experienced CVD and all-cause mortality events, respectively. Regarding CVD events, fasting plasma glucose (FPG) level of 7.22-<10 mmol/L [hazard ratio (HR): 1.46, 95% CI 1.12-1.96], FPG level >= 10 mmol/L (HR 2.04, 1.53-2.72), hypertension (HR 1.65, 1.28-2.13), hypercholesterolaemia (HR 1.96, 1.40-2.75) and high waist to hip ratio (HR 1.30, 0.99-1.70; p=0.051) were significant predictors, and corresponding population attributable fractions were 9.76, 17.84, 23.26, 41.63 and 14.76%, respectively. Considering all-cause mortality events, hypertension (HR 1.70, 1.23-2.36), FPG level >= 10 mmol/L (HR 2.31, 1.55-3.20) and smoking (HR 1.45, 1.03-2.04) were significant predictors, and corresponding population attributable fractions were 25.81, 20.88 and 11.18%, respectively. Meanwhile, being overweight or obese was associated with lower all-cause and CVD mortality events. Conclusions Among modifiable risk factors in patients with type 2 diabetes, hypercholesterolaemia and central adiposity for CVD, smoking for mortality events and hypertension and poor glycaemic control for both outcomes need to be paid most attention by healthcare professionals. Copyright (C) 2016 John Wiley & Sons, Ltd.
引用
收藏
页码:596 / 606
页数:11
相关论文
共 50 条
  • [1] Microvascular Disease Burden and All-Cause Mortality in Type 1 Diabetes-A 10-Year Follow-Up Study
    Garofolo, Monia
    Giannarelli, Rosa
    Aragona, Michele
    Lucchesi, Daniela
    Giusti, Laura
    Sancho-Bornez, Veronica
    Daniele, Giuseppe
    Miccoli, Roberto
    Penno, Giuseppe
    Del Prato, Stefano
    [J]. DIABETES, 2018, 67
  • [2] Weight fluctuation, mortality, and cardiovascular disease in adults in 18 years of follow-up: Tehran Lipid and Glucose Study
    L. Mehran
    M. Honarvar
    S. Masoumi
    D. Khalili
    A. Amouzegar
    F. Azizi
    [J]. Journal of Endocrinological Investigation, 2023, 46 : 37 - 49
  • [3] Weight fluctuation, mortality, and cardiovascular disease in adults in 18 years of follow-up: Tehran Lipid and Glucose Study
    Mehran, L.
    Honarvar, M.
    Masoumi, S.
    Khalili, D.
    Amouzegar, A.
    Azizi, F.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2023, 46 (01) : 37 - 49
  • [4] Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran Lipid and Glucose Study
    Seyyed Saeed Moazzeni
    Reyhane Hizomi Arani
    Niloofar Deravi
    Mitra Hasheminia
    Davood Khalili
    Fereidoun Azizi
    Farzad Hadaegh
    [J]. Cardiovascular Diabetology, 20
  • [5] Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran Lipid and Glucose Study
    Moazzeni, Seyyed Saeed
    Arani, Reyhane Hizomi
    Deravi, Niloofar
    Hasheminia, Mitra
    Khalili, Davood
    Azizi, Fereidoun
    Hadaegh, Farzad
    [J]. CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [6] Estimated Glucose Disposal Rate as a Predictor of All-Cause Mortality in Type 1 Diabetes-A 10-Year Follow-Up Study
    Garofolo, Monia
    Bertolotto, Alessandra
    Campi, Fabrizio
    Lucchesi, Daniela
    Giusti, Laura
    Sancho-Bornez, Veronica
    Dardano, Angela
    Miccoli, Roberto
    Penno, Giuseppe
    Del Prato, Stefano
    [J]. DIABETES, 2018, 67
  • [7] Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease - 10-year follow-up of the Hoorn Study
    Becker, A
    Bos, G
    de Vegt, F
    Kostense, PJ
    Dekker, JM
    Nijpels, G
    Heine, RJ
    Bouter, LM
    Stehouwer, CDA
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 (15) : 1406 - 1413
  • [8] Lipoprotein(a) as a risk factor for cardiovascular mortality in type 2 diabetic patients -: A 10-year follow-up study
    Hernández, C
    Francisco, G
    Chacón, P
    Simó, R
    [J]. DIABETES CARE, 2005, 28 (04) : 931 - 933
  • [9] 10-year follow-up of intensive glucose control in type 2 diabetes
    Holman, Rury R.
    Paul, Sanjoy K.
    Bethel, M. Angelyn
    Matthews, David R.
    Neil, H. Andrew W.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (15): : 1577 - 1589
  • [10] A 10-Year Cardiovascular Risk in Adults with Different Levels of Spiritual Health: Tehran Lipid and Glucose Study
    Amiri, Parisa
    Ghadirian, Fataneh
    Parvin, Parnian
    Cheraghi, Leila
    Khalili, Davood
    Alamdari, Shahram
    Azizi, Fereidoun
    [J]. GLOBAL HEART, 2023, 18 (01)